Benefit risk evaluation of olanzapine, risperidone and sertindole in the treatment of schizophrenia:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Darmstadt
Steinkopff
1999
Berlin Springer |
| Schriftenreihe: | European archives of psychiatry and clinical neuroscience
Vol. 249, Suppl. 2 |
| Schlagworte: | |
| Beschreibung: | Einzelaufnahme eines Zs.-Suppl. |
| Beschreibung: | 14 S. graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV013486531 | ||
| 003 | DE-604 | ||
| 005 | 20010219 | ||
| 007 | t | ||
| 008 | 001205s1999 gw d||| |||| 00||| eng d | ||
| 016 | 7 | |a 960101578 |2 DE-101 | |
| 035 | |a (OCoLC)76205760 | ||
| 035 | |a (DE-599)BVBBV013486531 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 044 | |a gw |c DE | ||
| 049 | |a DE-12 | ||
| 245 | 1 | 0 | |a Benefit risk evaluation of olanzapine, risperidone and sertindole in the treatment of schizophrenia |c Siegfried Kasper ... |
| 264 | 1 | |a Darmstadt |b Steinkopff |c 1999 | |
| 264 | 1 | |a Berlin |b Springer | |
| 300 | |a 14 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a European archives of psychiatry and clinical neuroscience |v Vol. 249, Suppl. 2 | |
| 500 | |a Einzelaufnahme eines Zs.-Suppl. | ||
| 650 | 0 | 7 | |a Risperidon |0 (DE-588)4331556-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Schizophrenie |0 (DE-588)4052527-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Olanzapin |0 (DE-588)4614091-8 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Sertindol |0 (DE-588)4614093-1 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Schizophrenie |0 (DE-588)4052527-2 |D s |
| 689 | 0 | 1 | |a Olanzapin |0 (DE-588)4614091-8 |D s |
| 689 | 0 | 2 | |a Risperidon |0 (DE-588)4331556-2 |D s |
| 689 | 0 | 3 | |a Sertindol |0 (DE-588)4614093-1 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Kasper, Siegfried |d 1950- |e Sonstige |0 (DE-588)11803166X |4 oth | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-009205165 | ||
Datensatz im Suchindex
| _version_ | 1804128278034776064 |
|---|---|
| any_adam_object | |
| author_GND | (DE-588)11803166X |
| building | Verbundindex |
| bvnumber | BV013486531 |
| ctrlnum | (OCoLC)76205760 (DE-599)BVBBV013486531 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01449nam a2200409 cb4500</leader><controlfield tag="001">BV013486531</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20010219 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">001205s1999 gw d||| |||| 00||| eng d</controlfield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">960101578</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)76205760</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV013486531</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">DE</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Benefit risk evaluation of olanzapine, risperidone and sertindole in the treatment of schizophrenia</subfield><subfield code="c">Siegfried Kasper ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Darmstadt</subfield><subfield code="b">Steinkopff</subfield><subfield code="c">1999</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Berlin</subfield><subfield code="b">Springer</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">14 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">European archives of psychiatry and clinical neuroscience</subfield><subfield code="v">Vol. 249, Suppl. 2</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Einzelaufnahme eines Zs.-Suppl.</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Risperidon</subfield><subfield code="0">(DE-588)4331556-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Schizophrenie</subfield><subfield code="0">(DE-588)4052527-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Olanzapin</subfield><subfield code="0">(DE-588)4614091-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Sertindol</subfield><subfield code="0">(DE-588)4614093-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Schizophrenie</subfield><subfield code="0">(DE-588)4052527-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Olanzapin</subfield><subfield code="0">(DE-588)4614091-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Risperidon</subfield><subfield code="0">(DE-588)4331556-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Sertindol</subfield><subfield code="0">(DE-588)4614093-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kasper, Siegfried</subfield><subfield code="d">1950-</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)11803166X</subfield><subfield code="4">oth</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-009205165</subfield></datafield></record></collection> |
| id | DE-604.BV013486531 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T18:46:42Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-009205165 |
| oclc_num | 76205760 |
| open_access_boolean | |
| owner | DE-12 |
| owner_facet | DE-12 |
| physical | 14 S. graph. Darst. |
| publishDate | 1999 |
| publishDateSearch | 1999 |
| publishDateSort | 1999 |
| publisher | Steinkopff Springer |
| record_format | marc |
| series2 | European archives of psychiatry and clinical neuroscience |
| spelling | Benefit risk evaluation of olanzapine, risperidone and sertindole in the treatment of schizophrenia Siegfried Kasper ... Darmstadt Steinkopff 1999 Berlin Springer 14 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier European archives of psychiatry and clinical neuroscience Vol. 249, Suppl. 2 Einzelaufnahme eines Zs.-Suppl. Risperidon (DE-588)4331556-2 gnd rswk-swf Schizophrenie (DE-588)4052527-2 gnd rswk-swf Olanzapin (DE-588)4614091-8 gnd rswk-swf Sertindol (DE-588)4614093-1 gnd rswk-swf Schizophrenie (DE-588)4052527-2 s Olanzapin (DE-588)4614091-8 s Risperidon (DE-588)4331556-2 s Sertindol (DE-588)4614093-1 s DE-604 Kasper, Siegfried 1950- Sonstige (DE-588)11803166X oth |
| spellingShingle | Benefit risk evaluation of olanzapine, risperidone and sertindole in the treatment of schizophrenia Risperidon (DE-588)4331556-2 gnd Schizophrenie (DE-588)4052527-2 gnd Olanzapin (DE-588)4614091-8 gnd Sertindol (DE-588)4614093-1 gnd |
| subject_GND | (DE-588)4331556-2 (DE-588)4052527-2 (DE-588)4614091-8 (DE-588)4614093-1 |
| title | Benefit risk evaluation of olanzapine, risperidone and sertindole in the treatment of schizophrenia |
| title_auth | Benefit risk evaluation of olanzapine, risperidone and sertindole in the treatment of schizophrenia |
| title_exact_search | Benefit risk evaluation of olanzapine, risperidone and sertindole in the treatment of schizophrenia |
| title_full | Benefit risk evaluation of olanzapine, risperidone and sertindole in the treatment of schizophrenia Siegfried Kasper ... |
| title_fullStr | Benefit risk evaluation of olanzapine, risperidone and sertindole in the treatment of schizophrenia Siegfried Kasper ... |
| title_full_unstemmed | Benefit risk evaluation of olanzapine, risperidone and sertindole in the treatment of schizophrenia Siegfried Kasper ... |
| title_short | Benefit risk evaluation of olanzapine, risperidone and sertindole in the treatment of schizophrenia |
| title_sort | benefit risk evaluation of olanzapine risperidone and sertindole in the treatment of schizophrenia |
| topic | Risperidon (DE-588)4331556-2 gnd Schizophrenie (DE-588)4052527-2 gnd Olanzapin (DE-588)4614091-8 gnd Sertindol (DE-588)4614093-1 gnd |
| topic_facet | Risperidon Schizophrenie Olanzapin Sertindol |
| work_keys_str_mv | AT kaspersiegfried benefitriskevaluationofolanzapinerisperidoneandsertindoleinthetreatmentofschizophrenia |